Across multiple published studies, the test consistently identifies high-risk patients whose progression rates exceed guideline-based actionable thresholds for intensified care FRIENDSWOOD, Texas, Dec ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present new data supporting the ability ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company advancing innovative cancer diagnostics, announced that Precision Pathology Services, a CAP/CLIA-certified ...

Please provide your email address to receive an email when new articles are posted on . The AD2 blood test was roughly 90% accurate at Alzheimer’s identification. Diagnoses of subjective cognitive ...

Rules out Alzheimer's pathology in early stages to enhance diagnostic pathway efficiency Provides new opportunity to broaden access and improve referral quality Features as part of Roche's growing ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

The study, published in Gastroenterology, shows TissueCypher can increase the detection of Barrett’s esophagus (BE) patients with an initial diagnosis of low-grade dysplasia (LGD) who will progress to ...

Please provide your email address to receive an email when new articles are posted on . A new blood test may be able to detect Alzheimer’s disease-related pathology up to 10 years before symptoms ...

Congratulations to Marisa Marques, M.D., Professor, Laboratory Medicine, who has accepted a nomination to join the American Board of Pathology (ABPath) Test Development and Advisory Committee for ...